| 臺大學術典藏 |
2022-03-08T03:44:03Z |
Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer
|
Chen B.-B.; Tien Y.-W.; Chang M.-C.; Cheng M.-F.; Chang Y.-T.; SHIH-HUNG YANG; Wu C.-H.; Kuo T.-C.; Shih I.-L.; Yen R.-F.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-03-08T03:44:02Z |
S-1�Vassociated hypertriglyceridemia in a patient with pancreatic adenocarcinoma
|
Chen H.-W.; Kuo H.-Y.; Chen B.-B.; Tien Y.-W.; Kuo S.-H.; SHIH-HUNG YANG |
| 臺大學術典藏 |
2022-03-08T03:44:02Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
SHIH-HUNG YANG; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
SHIH-HUNG YANG; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:00Z |
Metabolic alterations in pancreatic cancer detected by in vivo1h-mr spectroscopy: Correlation with normal pancreas, pet metabolic activity, clinical stages, and survival outcome
|
Chang C.-K.; Shih T.T.-F.; Tien Y.-W.; Chang M.-C.; Chang Y.-T.; SHIH-HUNG YANG; Cheng M.-F.; Chen B.-B. |
| 臺大學術典藏 |
2022-03-08T03:44:00Z |
C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin �\v
|
Kuo T.-C.; Wu M.-H.; SHIH-HUNG YANG; Chen S.-T.; Hsu T.-W.; Jhuang J.-Y.; Liao Y.-Y.; Tien Y.-W.; Huang M.-C. |
| 臺大學術典藏 |
2022-03-08T03:43:59Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
Kuo S.-H.; SHIH-HUNG YANG; Wei M.-F.; Lee H.-W.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:43:59Z |
Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma
|
Chuang P.-J.; Wang H.-P.; Lin Y.-J.; Chen C.-C.; Tien Y.-W.; Hsieh M.-S.; SHIH-HUNG YANG; Yen R.-F.; Ko C.-L.; Wu Y.-W.; Cheng M.-F. |
| 臺大學術典藏 |
2022-03-08T03:43:58Z |
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
|
Chen Y.-L.; Tsai C.-L.; Cheng J.C.-H.; Wang C.-W.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:32Z |
Pancreatic carcinoma cells stimulate proliferation and matrix synthesis of hepatic stellate cells
|
Tien Y.-W.; Wu Y.-M.; WEI-CHOU LIN; Lee H.-S.; Lee P.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:26Z |
Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma
|
Chang M.-C.; CHIEN-HUNG CHEN; Liang J.-D.; Tien Y.-W.; Hsu C.; Wong J.-M.; Chang Y.-T. |
| 臺大學術典藏 |
2022-02-22T05:34:17Z |
Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma
|
Chang M.-C.; CHIEN-HUNG CHEN; Liang J.-D.; Tien Y.-W.; Hsu C.; Wong J.-M.; Chang Y.-T. |
| 臺大學術典藏 |
2022-02-21T02:04:31Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
Kuo S.-H.; Yang S.-H.; Wei M.-F.; Lee H.-W.; Tien Y.-W.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2022-02-18T08:46:48Z |
Low accuracy of chromogranin a for diagnosing early-stage pancreatic neuroendocrine tumors
|
Tseng C.-M.; Cheng T.-Y.; Chen T.-B.; Tien Y.-W.; CHIEN-CHUAN CHEN; Lin J.-T.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-18T08:25:52Z |
Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma
|
Chuang P.-J.; Wang H.-P.; Lin Y.-J.; CHIEH-CHANG CHEN; Tien Y.-W.; Hsieh M.-S.; Yang S.-H.; Yen R.-F.; Ko C.-L.; Wu Y.-W.; Cheng M.-F. |
| 臺大學術典藏 |
2022-02-14T07:10:51Z |
Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer
|
Wu H.-H.; Tsai L.-H.; Huang C.-K.; Hsu P.-H.; Chen M.-Y.; Chen Y.-I.; Hu C.-M.; Shen C.-N.; Lee C.-C.; Chang M.-C.; Chang Y.-T.; Tien Y.-W.; YUNG-MING JENG; Lee E.Y.-H.P.; Lee W.-H. |
| 臺大學術典藏 |
2022-02-14T07:10:49Z |
Local islet remodelling associated with duct lesion–islet complex in adult human pancreas
|
Tien Y.-W.; Chien H.-J.; Chiang T.-C.; Chung M.-H.; Lee C.-Y.; Peng S.-J.; Chen C.-C.; Chou Y.-H.; Hsiao F.-T.; YUNG-MING JENG; Tang S.-C. |
| 臺大學術典藏 |
2022-02-14T05:27:15Z |
Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma
|
Chuang P.-J.; HSIU-PO WANG; Lin Y.-J.; Chen C.-C.; Tien Y.-W.; Hsieh M.-S.; Yang S.-H.; Yen R.-F.; Ko C.-L.; Wu Y.-W.; Cheng M.-F. |
| 臺大學術典藏 |
2022-02-07T07:49:00Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
Yang S.-H.; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; SUNG-HSIN KUO; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-02-07T07:48:56Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
SUNG-HSIN KUO; Yang S.-H.; Wei M.-F.; Lee H.-W.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-01-25T05:10:42Z |
Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis
|
Chang M.-C.; Chang Y.-T.; Su T.-C.; Yang W.-S.; CHI-LING CHEN; Tien Y.-W.; Liang P.-C.; Wei S.-C.; Wong J.-M. |
| 臺大學術典藏 |
2022-01-08T04:31:30Z |
Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma
|
Chuang P.-J.; Wang H.-P.; Lin Y.-J.; Chen C.-C.; Tien Y.-W.; MIN-SHU HSIEH; Yang S.-H.; Yen R.-F.; Ko C.-L.; Wu Y.-W.; Cheng M.-F. |
| 臺大學術典藏 |
2022-01-07T06:06:02Z |
Solid pseudopapillary neoplasms of the pancreas: Is there a pathologic basis for the observed gender differences in incidence?
|
Tien Y.-W.; Ser K.-H.; Hu R.-H.; CHIH-YUAN LEE; Jeng Y.-M.; Lee P.-H. |
| 臺大學術典藏 |
2022-01-07T06:05:59Z |
Surgery for gastrointestinal stromal tumors of the duodenum
|
Tien Y.-W.; CHIH-YUAN LEE; Huang C.-C.; Hu R.-H.; Lee P.-H. |
| 臺大學術典藏 |
2022-01-07T06:05:48Z |
Human pancreatic afferent and efferent nerves: Mapping and 3-D illustration of exocrine, endocrine, and adipose innervation
|
Chien H.-J.; Chiang T.-C.; Peng S.-J.; Chung M.-H.; Chou Y.-H.; CHIH-YUAN LEE; Jeng Y.-M.; Tien Y.-W.; Tang S.-C. |
| 臺大學術典藏 |
2022-01-07T06:05:48Z |
Lymphatic vessel remodeling and invasion in pancreatic cancer progression
|
Shen C.-N.; Goh K.-S.; Huang C.-R.; Chiang T.-C.; CHIH-YUAN LEE; Jeng Y.-M.; Peng S.-J.; Chien H.-J.; Chung M.-H.; Chou Y.-H.; Hsieh C.-C.; Kulkarni S.; Pasricha P.J.; Tien Y.-W.; Tang S.-C. |
| 臺大學術典藏 |
2022-01-07T06:05:46Z |
The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells
|
Kung P.-J.; Lai T.-Y.; Cao J.; Hsu L.-C.; Chiang T.-C.; Ou-Yang P.; Tsai C.-Y.; Tsai Y.-F.; Lin C.-W.; Chen C.-C.; Tsai M.-K.; Tien Y.-W.; CHIH-YUAN LEE |
| 臺大學術典藏 |
2022-01-07T06:05:45Z |
Local islet remodelling associated with duct lesion–islet complex in adult human pancreas
|
Tien Y.-W.; Chien H.-J.; Chiang T.-C.; Chung M.-H.; CHIH-YUAN LEE; Peng S.-J.; Chen C.-C.; Chou Y.-H.; Hsiao F.-T.; Jeng Y.-M.; Tang S.-C. |
| 臺大學術典藏 |
2022-01-05T03:36:40Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
Yang S.-H.; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2022-01-05T03:36:38Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
Kuo S.-H.; Yang S.-H.; Wei M.-F.; Lee H.-W.; Tien Y.-W.; Cheng A.-L.; KUN-HUEI YEH |
| 國立成功大學 |
2022 |
Selective and antagonist-dependent �-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone
|
Lin, S.-Y.;Tien, Y.-W.;Ke, Y.-Y.;Chang, Y.-C.;Chang, H.-F.;Ou, L.-C.;Law, P.-Y.;Xi, J.-H.;Tao, P.-L.;Loh, H.H.;Chao, Y.-S.;Shih, C.;Chen, Chen C.-T.;Yeh, S.-H.;Ueng, S.-H. |
| 國立成功大學 |
2022 |
Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design
|
Yeh, T.-K.;Song, J.-S.;Chang, P.-W.;Yu, J.-C.;Chang, Chang C.-H.;Liao, F.-Y.;Tien, Y.-W.;Kuppusamy, R.;Li, A.-S.;Chen, Chen C.-H.;Chen, Chen C.-W.;Lin, Lin L.-M.;Chang, H.-H.;Huang, C.-H.;Yao, J.-Y.;Wu, M.-H.;Peng, Y.-H.;Hsueh, C.-C.;Hsiao, W.-C.;Chen, P.-H.;Lin, C.-Y.;Hsieh, S.-H.;Shih, C.;Hung, M.-S.;Wu, S.-Y.;Kuo, C.-C.;Ueng, S.-H. |
| 臺大學術典藏 |
2021-10-28T03:47:33Z |
Comparison of dexmedetomidine versus propofol on hemodynamics in surgical critically ill patients
|
Chang Y.-F.; Chao A.; Shih P.-Y.; YEN-CHUN HSU; Lee C.-T.; Tien Y.-W.; Yeh Y.-C.; Chen L.-W.; NTUH Center of Microcirculation Medical Research (NCMMR) |
| 臺大學術典藏 |
2021-09-01T01:54:22Z |
Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment
|
Shao Y.-Y.; Lin Z.-Z.; Liang P.-C.; Tien Y.-W.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:18Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; ANN-LII CHENG; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
Yang S.-H.; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:46Z |
Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κb is associated with a poor prognosis of pancreatic cancer
|
Yang S.-H.; Hsu C.-H.; Lee J.-C.; Tien Y.-W.; Kuo S.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:42Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang S.-H.; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; ANN-LII CHENG; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:41Z |
Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer
|
Yang S.-H.; Guo J.-C.; Yeh K.-H.; Tien Y.-W.; ANN-LII CHENG; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:35Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:21Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
Yang S.-H.; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-18T07:39:08Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang S.-H.; Kuo T.-C.; Wu H.; JHE-CYUAN GUO; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-18T07:39:08Z |
Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer
|
Yang S.-H.; JHE-CYUAN GUO; Yeh K.-H.; Tien Y.-W.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-18T07:39:07Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; JHE-CYUAN GUO; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-18T07:39:04Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
Yang S.-H.; JHE-CYUAN GUO; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-12T04:01:31Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
YANG SHIH-HUNG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-12T04:01:29Z |
Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-�eb is associated with a poor prognosis of pancreatic cancer
|
YANG SHIH-HUNG; Hsu C.-H.; Lee J.-C.; Tien Y.-W.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-12T04:01:28Z |
Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma
|
Chang M.-C.; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; Yang C.-Y.; Tien Y.-W.; YANG SHIH-HUNG; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. |
| 臺大學術典藏 |
2021-08-12T04:01:27Z |
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis
|
Chen B.-B.; Tien Y.-W.; Chang M.-C.; Cheng M.-F.; Chang Y.-T.; Wu C.-H.; Chen X.-J.; Kuo T.-C.; YANG SHIH-HUNG; Shih I.-L.; Lai H.-S.; Shih T.T.-F. |
